Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
Alimentary Pharmacology & Therapeutics2014Vol. 40(11-12), pp. 1313–1323
Citations Over TimeTop 10% of 2014 papers
Nicholas A. Kennedy, Rahul Kalla, Ben Warner, C. J. Gambles, R. Musy, Spencer Reynolds, Rakesh Dattani, H. Nayee, Richard Felwick, Richard Harris, Sue Marriott, S. M. H. M. K. Senanayake, Christopher A Lamb, H. Al‐Hilou, Daniel R. Gaya, Peter M. Irving, John Mansfield, Miles Parkes, Tariq Ahmad, Fraser Cummings, Ian Arnott, Jack Satsangi, Alan Lobo, Melissa Smith, James O. Lindsay, Charlie W. Lees
Abstract
Thiopurine withdrawal in the context of sustained remission is associated with a 1-year moderate-to-severe relapse rate of 23% in Crohn's disease and 12% in ulcerative colitis.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)